Literature DB >> 8835595

Relationship between dyspnea in daily life and psycho-physiologic state in patients with chronic obstructive pulmonary disease during long-term domiciliary oxygen therapy.

M Mishima1, Y Oku, S Muro, T Hirai, K Chin, M Ohi, M Nakagawa, M Fujita, K Sato, K Shimada, S Yamaoka, Y Oda, N Asai, Y Sagawa, K Kuno.   

Abstract

We examined the relationships among dyspnea ratings in daily life, the physiologic state, and anxiety and depression of fifty-two patients with chronic obstructive disease (COPD) during long-term domiciliary oxygen therapy (LTOT). Clinical ratings of dyspnea were assessed by the visual-analog scale (VAS) during eight types of basic behavior in indoor daily life. Analysis of the physiologic state included forced expiratory volume in 1 second (FEV1.0), and arterial blood gas (PaO2, PaCO2) at rest while breathing room air. The hospital anxiety and depression (HAD) scale, which consists of 14 questions, was used to assess the degree of anxiety (HAD-A) and depression (HAD-D). The mean age of the patients was 69.5 +/- 10.8 year (SD), and the duration of LTOT was 944 +/- 739 days. The mean values were 0.77 +/- 0.45 L for FEV1.0, 57.7 +/- 7.4 Torr for PaO2, and 47.4 +/- 8.1 Torr for PaCO2. FEV1.0 was correlated with PaCO2(r = -0.548, p < 0.0001), but it was not correlated with PaO2. High correlation was noted between HAD-A and HAD-D (r = 0.693, P < 0.0001), whereas correlation was not noted between HAD and the physiologic state. VAS was significantly correlated with FEV1.0 (r = 0.320, p < 0.05), as well as with HAD-A (r = 0.358, p < 0.01) and HAD-D (r = 0.444, p < 0.01). Dyspnea ratings were found to be influenced by anxiety and the depression state, and also by the degree of flow limitation in patients with COPD during LTOT. In contrast, the physiologic state scarcely influenced the anxiety and depression state. Thus, psychotherapy may play an important role in the reduction of dyspnea sensation, which is an important determinant of quality of life.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8835595     DOI: 10.2169/internalmedicine.35.453

Source DB:  PubMed          Journal:  Intern Med        ISSN: 0918-2918            Impact factor:   1.271


  8 in total

1.  Prevalence of alexithymia and its association with anxiety and depression in a sample of Greek chronic obstructive pulmonary disease (COPD) outpatients.

Authors:  Athanasios Tselebis; Epaminondas Kosmas; Dionisios Bratis; Georgios Moussas; Athanasios Karkanias; Ioannis Ilias; Nikolaos Siafakas; Alexandros Vgontzas; Nikolaos Tzanakis
Journal:  Ann Gen Psychiatry       Date:  2010-04-14       Impact factor: 3.455

2.  Family relationship quality is associated with psychological distress, dyspnea, and quality of life in COPD.

Authors:  Kristen E Holm; Russell P Bowler; Barry J Make; Frederick S Wamboldt
Journal:  COPD       Date:  2009-10       Impact factor: 2.409

3.  Factors Associated with Depression in COPD: A Multicenter Study.

Authors:  Carlos Martinez Rivera; Joaquín Costan Galicia; Bernardino Alcázar Navarrete; Cayo Garcia-Polo; Luis Alberto Ruiz Iturriaga; Alberto Herrejón; Jose Antonio Ros Lucas; Patricia García-Sidro; Gema Tirado-Conde; Jose Luis López-Campos; Sagrario Mayoralas Alises; Javier de Miguel-Díez; Cristina Esquinas; Marc Miravitlles
Journal:  Lung       Date:  2016-03-01       Impact factor: 2.584

Review 4.  Strategies to improve anxiety and depression in patients with COPD: a mental health perspective.

Authors:  Athanasios Tselebis; Argyro Pachi; Ioannis Ilias; Epaminondas Kosmas; Dionisios Bratis; Georgios Moussas; Nikolaos Tzanakis
Journal:  Neuropsychiatr Dis Treat       Date:  2016-02-09       Impact factor: 2.570

5.  The Association of Depression with Type D Personality and Coping Strategies in Patients with Coronary Artery Disease.

Authors:  Daisuke Yamaguchi; Atsushi Izawa; Yasuko Matsunaga
Journal:  Intern Med       Date:  2020-07-01       Impact factor: 1.271

6.  Resilience and health-related quality of life in patients with pulmonary diseases receiving ambulatory oxygen therapy.

Authors:  Siiri Isokääntä; Kirsi Honkalampi; Hannu Kokki; Harri Sintonen; Merja Kokki
Journal:  BMC Pulm Med       Date:  2021-05-01       Impact factor: 3.320

7.  Anxiety and depression in COPD patients and correlation with sputum and BAL cytology.

Authors:  Cuneyt Tetikkurt; Imran Ozdemir; Seza Tetikkurt; Nail Yılmaz; Turan Ertan; Nihal Bayar
Journal:  Multidiscip Respir Med       Date:  2011-08-31

8.  BODE index versus GOLD classification for explaining anxious and depressive symptoms in patients with COPD - a cross-sectional study.

Authors:  Georg-Christian Funk; Kathrin Kirchheiner; Otto Chris Burghuber; Sylvia Hartl
Journal:  Respir Res       Date:  2009-01-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.